Effects of Reduced Gcm1 Expression on Trophoblast Morphology, Fetoplacental Vascularity, and Pregnancy Outcomes in Mice
Authors:
- Shannon A. BainbridgeShannon A. Bainbridge
- Abhijeet MinhasAMAbhijeet Minhas
- Kathie J. WhiteleyKWKathie J. Whiteley
- Dawei QuDQDawei Qu
- John G. SledJSJohn G. Sled
- John C.P. KingdomJKJohn C.P. Kingdom
- S. Lee AdamsonSAS. Lee Adamson
- 1 March 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 59 (3) , 732-739
Abstract
Preeclampsia is a life-threatening disorder characterized by maternal gestational hypertension and proteinuria that results from placental dysfunction. Placental abnormalities include abnormal syncytiotrophoblast and a 50% reduction in placental expression of the transcription factor Gcm1 . In mice, homozygous deletion of Gcm1 prevents syncytiotrophoblast differentiation and is embryonic lethal. We used heterozygous Gcm1 mutants ( Gcm1 +/− ) to test the hypothesis that hypomorphic expression of placental Gcm1 causes defective syncytiotrophoblast differentiation and maternal and placental phenotypes that resemble preeclampsia. We mated wild-type female mice with Gcm1 +/− fathers to obtain wild-type mothers carrying ≈50% Gcm1 +/− conceptuses. Gcm1 +/− placentas had syncytiotrophoblast abnormalities including reduced gene expression of Gcm1 -regulated SynB , elevated expression of sFlt1 , a thickened interhemal membrane separating maternal and fetal circulations, and electron microscopic evidence in syncytiotrophoblast of necrosis and impaired maternal-fetal transfer. Fetoplacental vascularity was quantified by histomorphometry and microcomputed tomography imaging. In Gcm1 +/− , it was ≈30% greater than wild-type littermates, whereas placental vascular endothelial growth factor A ( Vegfa ) expression and fetal and placental weights did not differ. Wild-type mothers carrying Gcm1 +/− conceptuses developed late gestational hypertension (118±2 versus 109.6±0.7 mm Hg in controls; P Gcm1 expression in human control and pathological pregnancies and found that, as in mice, fetoplacental vascularity increased when GCM1 protein expression decreased ( R 2 =−0.45; P Gcm1 expression as a causative factor in defective syncytiotrophoblast differentiation and maternal and placental phenotypes in preeclampsia in humans.Keywords
This publication has 36 references indexed in Scilit:
- Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblastCell Death & Differentiation, 2009
- Early patterning of the chorion leads to the trilaminar trophoblast cell structure in the placental labyrinthDevelopment, 2008
- Impaired cytotrophoblast cell–cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunctionMolecular Reproduction and Development, 2007
- Apoptosis and its role in the trophoblastAmerican Journal of Obstetrics and Gynecology, 2006
- Latest Advances in Understanding PreeclampsiaScience, 2005
- Biochemical characterization of the human placental transcription factor GCMa/1Biochemistry and Cell Biology, 2005
- Apoptosis in the Trophoblast—Role of Apoptosis in Placental MorphogenesisJournal of the Society for Gynecologic Investigation, 2004
- Decreased Placental GCM1 (Glial Cells Missing) Gene Expression in Pre-eclampsiaPlacenta, 2004
- The potential to induce glial differentiation is conserved betweenDrosophilaand mammalian glial cells missing genesDevelopment, 2003
- Syncytin, a novel human endogenous retroviral gene in human placenta: Evidence for its dysregulation in preeclampsia and HELLP syndromeAmerican Journal of Obstetrics and Gynecology, 2002